The lightweight, wearable device ensures minimal disruption to a patient’s daily routine, all while providing faster reporting for healthcare professionals. This technological advancement accelerates the diagnostic process for cardiac conditions, offering more swift and efficient outcomes for patients.
Established in 2010 by consultant anaesthetist Dr. John T Doherty, JACE Medical offers a range of patient-focused services to the public, NHS, and the private sector. The group’s comprehensive offerings include testing, ambulance services, event cover, general medicals, training, and surgery, all delivered at their state-of-the-art facility.
Dr. Doherty, the visionary founder of JACE Medical, expressed his enthusiasm about the UltralinQ rollout, stating, “This is an extremely significant advancement for not just JACE Medical but for the entire cardiac health sector in Northern and the Republic of Ireland. We’re thrilled to be the first private healthcare providers in the country to offer the UltralinQ, and we look forward to not only extending this service to other clinicians but also to providing quicker and more effective diagnostic services to anyone concerned about their cardiac health.”
He further emphasised JACE Medical’s commitment to customised care, saying, “At JACE, our dedicated team of medical experts is committed to providing personalised care, ensuring your well-being is our top priority, and the UltralinQ launch is only an extension of that.”
For more information about the roll out, or to enquire if you can avail of the UltralinQ, please visit www.jacemedical.co.uk.
The JACE Medical Team
Advertisement
